MDRX - Allscripts Healthcare Solutions, Inc.
9.44 0.00 (0.00%)
After hours: 5:53PM EDT
| Previous Close | 9.16 |
| Open | 9.14 |
| Bid | 9.41 x 3000 |
| Ask | 10.15 x 2200 |
| Day's Range | 9.13 - 9.50 |
| 52 Week Range | 8.54 - 14.97 |
| Volume | 1,111,592 |
| Avg. Volume | 1,787,006 |
| Market Cap | 1.573B |
| Beta (3Y Monthly) | 1.38 |
| PE Ratio (TTM) | 8.91 |
| EPS (TTM) | 1.06 |
| Earnings Date | Oct 30, 2019 - Nov 4, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | 2008-10-07 |
| 1y Target Est | 12.06 |
- Business Wire
Veradigm and Komodo Health Partner to Create the Largest Linked EHR and Claims Dataset for Life Science Research
Veradigm, an Allscripts (MDRX) business unit, today announced that it has entered into a long-term strategic partnership with Komodo Health to advance life sciences research. Initially the partnership will focus on linking Allscripts’ industry-leading ambulatory EHR data with Komodo’s Healthcare Map, which contains encounter data from more than 150 private and public payers. Using Komodo Health’s platform, the collaboration will enable Veradigm to provide a linked dataset containing a complete longitudinal view of nearly 50 million deidentified patients to support life sciences companies as they investigate new ways to reduce disease burden.
- Business Wire
WOMBA LLC selects Veradigm™ to automate medical record retrieval implementing Veradigm eChart Courier™ with law firm clients
Veradigm™, an Allscripts (MDRX), business unit, dedicated to simplifying healthcare with data driven health insights and technologies to help manage cost and improve health outcomes, announced today an agreement with WOMBA, LLC, a leading provider of health record retrieval and consolidation to the Life Insurance, Long Term Care, Disability and Legal industries, to automate medical record requests via Veradigm eChart Courier™. WOMBA will utilize Veradigm’s eChart Courier to provide medical chart records to attorneys in an automated, secure and HIPAA compliant manner, pursuant to authorization from patients who are clients. This solution streamlines a time consuming and resource intensive process for attorneys, their clients and, healthcare providers.
- Thomson Reuters StreetEvents
Edited Transcript of MDRX earnings conference call or presentation 8-Aug-19 8:30pm GMT
Q2 2019 Allscripts Healthcare Solutions Inc Earnings Call
- Zacks
Here's Why You Should Invest in Cooper Companies Stock Now
Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across segments and prudent acquisitions.
- Zacks
MDRX vs. NXGN: Which Stock Is the Better Value Option?
MDRX vs. NXGN: Which Stock Is the Better Value Option?
- Business Wire
Q-State Biosciences and 2bPrecise Announce Partnership
Initiative designed to accelerate discovery of genetically targeted medicines and broaden options for enhanced patient care
- Zacks
Here's Why You Should Invest in HMS Holdings (HMSY) Stock Now
HMS Holdings (HMSY) is gaining traction from the growing PI and TPM analytical services as well as robust margins.
- Business Wire
Hendrick Health System leverages Allscripts EHR to achieve HIMSS Analytics EMRAM Stage 7
Allscripts (MDRX) client Hendrick Health System, located in Abilene, TX, has achieved the prestigious Stage 7, the highest level attainable, on the HIMSS Analytics Electronic Medical Record Adoption Model (EMRAM). This award recognizes Hendrick Health System’s adoption of technology to optimize patient care in a seamless patient record environment using a single Electronic Health Record (EHR) throughout the enterprise.
- Zacks
Allscripts (MDRX) Q2 Earnings Top Estimates, Revenues Lag
Allscripts (MDRX) second-quarter results gain from growth in bookings and solid show by client services segment. Contraction in operating margin remains a woe.
- Motley Fool
What's Behind Allscripts' Mixed Q2 Results
Here's why the healthcare technology provider narrowly beat analysts' earnings estimates in Q2 but missed on revenue expectations.
Motley FoolAllscripts (MDRX) Q2 2019 Earnings Call Transcript
MDRX earnings call for the period ending June 30, 2019.
- Zacks
AllScripts Healthcare (MDRX) Beats Q2 Earnings Estimates
AllScripts (MDRX) delivered earnings and revenue surprises of 6.25% and -0.72%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
Allscripts Announces Second Quarter 2019 Results
CHICAGO-- -- Strong second quarter bookings of $276 million up 31% from the prior year period Raised 2019 bookings outlook to between $1,050 million and $1,100 million Reached agreement in principle with the DOJ that, if finalized, is intended to resolve all matters related to the investigation of Practice Fusion Allscripts Healthcare Solutions, Inc. announced its financial results for the three and ...
- Zacks
Earnings Preview: AllScripts Healthcare (MDRX) Q2 Earnings Expected to Decline
AllScripts (MDRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
Calculating The Fair Value Of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Allscripts Healthcare...
- GlobeNewswire
DigitalOcean Appoints New CEO and CFO to Position Company for Its Next Phase of Growth
DigitalOcean, the cloud for developing modern apps, today announced that it has appointed Yancey Spruill as its new Chief Executive Officer. Spruill replaces Mark Templeton, who announced his decision in May 2019 to step down due to personal reasons and has been working closely with the company’s board to identify a successor. DigitalOcean also appointed Bill Sorenson as its new Chief Financial Officer, who will help scale the company’s global finance organization.
- American City Business Journals
Hot IPO company Livongo's CEO was once a fierce rival with its founder
On the day of Livongo's soaring IPO, CEO Zane Burke recalls his once fierce rivalry with founder and chairman Glen Tullman.
- Zacks
MDRX or CERN: Which Is the Better Value Stock Right Now?
MDRX vs. CERN: Which Stock Is the Better Value Option?
- Business Wire
Allscripts to Release Second-Quarter 2019 Financial Results August 8
Allscripts management plans to host a conference call and webcast to discuss the company's earnings and other information at 4:30 p.m. Eastern Time that same day. The Allscripts earnings announcement will be distributed immediately after the close of regular stock market hours on August 8, 2019. The announcement will also be available at Allscripts investor relations website.
- Business Wire
St. Luke’s Medical Center Selects Allscripts Sunrise™
St. Luke’s Medical Center, located in the Philippines, has selected Allscripts (MDRX) Sunrise™ Acute Care as its electronic health record (EHR) to achieve the goal of standardization across its facilities via a single, integrated EHR. St. Luke’s Medical Center further represents the company’s growing momentum in territories outside of the United States.
- Zacks
MDRX vs. CERN: Which Stock Should Value Investors Buy Now?
MDRX vs. CERN: Which Stock Is the Better Value Option?
- Business Wire
Allscripts offers a new option for Microsoft’s HealthVault users to transition their health data
Allscripts (MDRX) announced its patient and consumer engagement platform, FollowMyHealth, as a platform for existing Microsoft HealthVault users to transition and share their health data with family, friends or their home care team when required. FollowMyHealth offers a streamlined option for users to export their existing data and continue tracking their health online or through its mobile apps on iOS and Android.
- Business Wire
Veradigm™ Partners with American College of Cardiology to develop next-generation research network: NCDR PINNACLE and Diabetes Collaborative Registries
Veradigm™, an Allscripts (MDRX), business unit dedicated to simplifying healthcare with data driven health insights and technologies to help manage costs and improve health outcomes, announced today that it has partnered with the American College of Cardiology (ACC) to power the next generation of real-world research on behalf of cardiovascular disease and diabetes patients around the world. As part of this partnership, Veradigm will operate the PINNACLE Registry®, which focuses on coronary artery disease, hypertension, heart failure, atrial fibrillation and diabetes in the outpatient setting, and the Diabetes Collaborative Registry, the first global, cross-specialty clinical registry designed to track and improve the quality of diabetes and metabolic care across the primary care and specialty care continuum from the American College of Cardiology.
- Zacks
Here's Why You Should Retain Allscripts (MDRX) Stock Now
Allscripts (MDRX) is gaining steadily from strategic acquisitions and solid prospects in Sunrise EHR platform. However, integration risks remain a woe.
- Insider Monkey
Here is What Hedge Funds Think About Allscripts Healthcare Solutions Inc (MDRX)
Does Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) represent a good buying opportunity at the moment? Let’s quickly check the hedge fund interest towards the company. Hedge fund firms constantly search out bright intellectuals and highly-experienced employees and throw away millions of dollars on satellite photos and other research activities, so it is no wonder why they […]
